A Deep Dive into the Updated Status of Targeted Co-stimulation: Success of Failure

Thurs., Dec. 12 |12–2 p.m. EST | Webinar

Hear recent updates in novel translational and clinical studies of co-stimulatory domains and ligands, their mechanisms of action, and how manipulation of these pathways can potentially improve the anti-cancer immune response.